XENE
Xenon Pharmaceuticals Inc.CIK 0001582313
Showing the last 10 days.Sign up free for 90 days
Activist & passive stakes
View all XENE stake filings- PassiveAmendment 1Nov 6, 2026Xenon Pharmaceuticals IncT. Rowe Price Investment Management, Inc.10.3% · 9,996,124 shSEC
- PassiveNewNov 6, 2026Xenon Pharmaceuticals IncT. Rowe Price Investment Management, Inc.8.2% · 7,905,757 shSEC
- PassiveAmendment 9Nov 5, 2026Xenon Pharmaceuticals IncFmr Llc11.5% · 11,136,649 shSEC
| Filing | Holder | % Owned | Shares | Filed | SEC filing |
|---|---|---|---|---|---|
PassiveAmendment 1 | T. Rowe Price Investment Management, Inc. in Xenon Pharmaceuticals Inc | 10.3% | 9,996,124 | Nov 6, 2026 | SEC |
PassiveNew | T. Rowe Price Investment Management, Inc. in Xenon Pharmaceuticals Inc | 8.2% | 7,905,757 | Nov 6, 2026 | SEC |
PassiveAmendment 9 | Fmr Llc in Xenon Pharmaceuticals Inc | 11.5% | 11,136,649 | Nov 5, 2026 | SEC |
Earnings
PaidCompany revenue, EPS, net income, and guidance the moment they file, parsed from SEC 8-K earnings releases. Create a free account to get started, then unlock earnings on a paid plan.
- Revenue and adjusted / GAAP EPS per quarter
- GAAP net income with profit and loss at a glance
- Forward EPS guidance when companies provide it